Advertisement
Clinical MedicineIn-Press PreviewDermatology Open Access | 10.1172/JCI179436
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Hwang, A. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Kechter, J. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Do, T. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Hughes, A. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Zhang, N. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Li, X. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Bogle, R. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Brumfiel, C. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Patel, M. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Boudreaux, B. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Bhullar, P. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Nassir, S. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Yousif, M. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Stockard, A. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Leibovit-Reiben, Z. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Ogbaudu, E. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by DiCaudo, D. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Fox, J. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Gharaee-Kermani, M. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Xing, X. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Zunich, S. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Branch, E. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Kahlenberg, J. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Billi, A. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Plazyo, O. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Tsoi, L. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Pittelkow, M. in: JCI | PubMed | Google Scholar
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Gudjonsson, J. in: JCI | PubMed | Google Scholar |
1Department of Dermatology, Mayo Clinic Arizona, Scottsdale, United States of America
2Department of Dermatology, University of Michigan, Ann Arbor, United States of America
3Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, United States of America
Find articles by Mangold, A. in: JCI | PubMed | Google Scholar
Published November 14, 2024 - More info
BACKGROUND. Cutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that interrupts the signaling pathway of interferon gamma (IFN)-γ, a cytokine implicated in the pathogenesis of LP.
METHODS. In this phase II trial, twelve patients with cutaneous LP received baricitinib 2 mg daily for 16 weeks, accompanied by in-depth spatial, single-cell, and bulk transcriptomic profiling of pre- and post-treatment samples.
RESULTS. An early and sustained clinical response was seen, with 83.3% of patients responsive at week 16. Our molecular data identified a unique, oligoclonal IFN-γ, CD8+, CXCL13+ cytotoxic T-cell population in LP skin and demonstrated a rapid decrease in IFN signature within 2 weeks of treatment, most prominently in the basal layer of the epidermis.
CONCLUSION. This study demonstrates the efficacy and molecular mechanisms of JAK inhibition in LP.
TRIAL REGISTRATION. NCT05188521.
ROLE OF FUNDING SOURCE. Eli Lilly, Appignani Benefactor Funds, 5P30AR075043, Mayo Clinic Clinical Trials Stimulus Funds.